The Disability Rights Critique of Technologies that Eliminate Human Genetic Variation
By Rosemarie Garland-Thomson,
ELSIhub
| 04. 12. 2023
Photo by Kimberly Farmer on Unsplash
Introduction
The development and use of an expanding range of medical technologies that yield genetic information about embryos and fetuses has raised ethical questions about whether and how this increasingly routine set of practices discriminates against people with disabilities. A conversation in the form of academic articles and public media offers explications and critiques about the social and moral harms human gene editing and prenatal genetic testing and the selective reproduction practices it prompts bring to humanity. These purported harms range from increased social inequity—at the very least—to structural and individual violence—at the very most.
This collection suggests that conversations about these technologies have changed over time and also reflects the varied communities engaged in those conversations over time and across social locations. The collection thus focuses on the health humanities in the broadest sense. This means that the data, evidence, and knowledge it gathers come from the lives of individuals, families, and human communities who live with disabilities and illnesses, not from medical-scientific or clinical data. The stories in the final section of...
Related Articles
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...
By Miguel Muñoz, Cadena SER [cites Marcy Darnovsky] | 08.04.2026
"Para ellos, una familia numerosa no solo es una preferencia personal, sino que es una obligación. Creen que tener tantos hijos como sea posible es necesario para evitar un futuro apocalíptico", aseguraba Xavier Orri, periodista y cofundador de Página Internacional...
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...
By Alex Polyakov, The Conversation | 02.09.2026
Prospective parents are being marketed genetic tests that claim to predict which IVF embryo will grow into the tallest, smartest or healthiest child.
But these tests cannot deliver what they promise. The benefits are likely minimal, while the risks to...